Abstract
Objective
The aim of our study was to detect the correlation between the expressions of HER2 and VEGF in breast cancer, and their relations with some pathological factors.
Methods
By immunohistochemistry technique, the expressions of HER2 and VEGF in the post-operation samples of 117 cases with breast cancer were assessed, and their relations with some pathological factors were analysed by statistical methods. Fifty samples of hyperplasia of mammary glands were observed as the control.
Results
The positive expression rates of HER2 and VEGF in breast cancer were both significantly higher than those in hyperplasia of mammary gland (P < 0.05). The expressions of HER2 and VEGF were both correlated to lymph node metastasis (P < 0.05), but showed no relations with age, histological type, histological stage, tumor size (P > 0.05). The positive expression rate of HER2 had a positive correlation with those of VEGF (P < 0.05, r = 0.373).
Conclusion
The expressions of HER2 and VEGF have no correlations with age, histological type, histological stage, tumor size, but are closely related with lymphatic metastasis. The positive expression rates of HER2 shows a positive correlation with those of VEGF.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Tsutsui S, Ohno S, Murakami S, et al. Prognostic value of c-erbB2 expression in breast cancer. Surg Oncol, 2002, 79: 216–223.
Sahin AA. Biologic and clinical significance of HER-2/neu (c-erbB-2) in breast cancer. Adv Anat Pathol, 2002, 7: 158–166.
Jiao D, Ren GS, et al. The development of HER2 research in breast cancer. Surg Foreign Med Sci (Chinese), 2005, 32: 374–377.
Lin YC, De Z, Wang HB, et al. Clinical significance of serum vascular endothelial growth factor in advanced malignant tumors. Chinese-German J Clin Oncol, 2008, 7: 611–614.
Wang YL, Zhou M, Chen T, et al. The analysis of the expression of VEGF and P53 in the serum of 50 cases of lung cancer. Mod Oncol (Chinese), 2005, 13: 811–812.
Peng HP, Guan H, Xiao HL, et al. The differential expression of p53, VEGF and MVD in breast cancer and tumor adjacent tissues and its clinical significance. J Chin Physician (Chinese), 2004, 6: 1297–1299.
Wang SM, Zhu CX, Li ZX, et al. Correlation between the angiogenic factors and the blood metastasis of breast cancer. Chin J Exp Surg (Chinese), 2005, 22: 524–526.
Laughner E, Taghavi P, Chiles K, et al. HER2 signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mole Cell Biol, 2001, 21: 3995–4004.
Yen L, You XL, AL Moustafa AE, et al. Heregnlin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis. Oncogene, 2000, 19: 3460–3469.
Yang W, Klos K, Yang Y, et al. ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma. Cancer, 2002, 94: 2855–2861.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ye, X., Lu, D. HER2 and VEGF expression in breast cancer and their correlations. Chin. -Ger. J. Clin. Oncol. 9, 208–212 (2010). https://doi.org/10.1007/s10330-010-0018-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10330-010-0018-6